跳至主要内容
临床试验/NCT01630031
NCT01630031Unknown不适用

Pulmonary Vein Isolation: Interest of Real-Time Contact Force Sensing During Radiofrequency Catheter Ablation for Paroxysmal Atrial Fibrillation

Clinique Pasteur1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2010年11月最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
Proportion of PVI after exclusive anatomic approach

研究概览

简要总结

Introduction - Pulmonary vein isolation (PVI) is the cornerstone of paroxysmal atrial fibrillation (AF) ablation. Recurrences remain, however, not infrequent and are mainly due to PVs reconnection. In this setting, all procedural means able to improve the quality of tissue lesions are welcome.

Study Hypothesis - A continuous sensing of contact force (CF) during ablation, offered by a new catheter available on the market, was a valuable additional tool increasing the efficacy of the ablation procedure for PVI.

Methods - Prospective observational non-randomized monocentric study. Patients with paroxysmal AF receive PVI following standard ablation procedures (linear antral catheter ablation guided by CARTO 3 System, Biosense Webster, Inc.) using either a new irrigated RF ablation catheter that provides tip-to-tissue CF information (THERMOCOOL SMARTTOUCH Catheter, Biosense Webster, Inc.) (CF group), or a non-CF irrigated catheter (THERMOCOOL SF or EZ STEER THERMOCOOL Catheter, Biosense Webster, Inc.) (control group). Overall, 60 consecutive patients are enrolled in the study, with 30 patients in each group. All procedures is performed by the same experienced operator, not blinded to the catheter used. Except for CF information (with an objective of at least 10 g, associated to the most perpendicular vector obtainable), ablation procedures are carried out using identical approaches in both groups. Patients are discharged from hospital free of antiarrhythmic therapy. Patients are enrolled in a specific follow-up plan.

Primary Endpoints -(1) Proportion of PVI after exclusive anatomic approach, (2) Proportion of patients free of AF after 12-month follow-up.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptomatic paroxysmal atrial fibrillation despite at least failure of one anti-arrhythmic drug
  • Age 18-75 yrs
  • First catheter ablation

排除标准

  • Left ventricle ejection fraction at echocardiography <50%
  • History of heart surgery

结局指标

主要结局

Proportion of PVI after exclusive anatomic approach

时间窗: Day 0

Proportion of patients free of AF after 12-month FU

时间窗: One year

次要结局

  • Total time of fluoroscopy and radiation exposure(Day 0)
  • Total time of RF application required for completed PVI(Day 0)
  • Proportion of pericardial effusion at echocardiography(Day 1)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

JP Albenque

M.D.

Clinique Pasteur

研究点 (1)

Loading locations...

相似试验

Contact Force Sensing and Pulmonary Vein Isolation | 临床试验